{
      "ptx_code": "PTX159",
      "chem_name": "3,3',5,5'-tetrabromobisphenol a",
      "casrn": "79-94-7",
      "dtxsid": "DTXSID1026081",
      "smiles": "CC(C)(C1=CC(Br)=C(O)C(Br)=C1)C1=CC(Br)=C(O)C(Br)=C1",
      "inchikey": "VEORPZCZECFIRK-UHFFFAOYSA-N",
      "label": "PTX159 | 3,3',5,5'-tetrabromobisphenol a",
      "drugbank_id": "",
      "use_class": "Industry and consumer goods",
      "tox_class": "Genotoxicity; Immunotoxicity; Neurotoxicity; Hepatotoxicity; Nephrotoxicity; Ototoxicity",
      "chem_name_user": "Tetrabromobisphenol a",
      "mw_g_mol": "543.875",
      "solubility_h2o_mol_liter": "1.78323e-06",
      "source_solubility_h2o": "COMPTOX (OPERA)",
      "henry_coefficient_atm_m3_mol": "1.76603e-08",
      "source_henry": "COMPTOX",
      "log_kaw_kh_rt": "6.14131159505788",
      "source_kaw": "LSER eq 1 exp. Descriptors",
      "pka_acid": "6.28;7.3",
      "pka_base": "",
      "source_pka": "Niu, L., et al. (2022). pH-Dependent Partitioning of Ionizable Organic Chemicals between the Silicone Polymer Polydimethylsiloxane (PDMS) and Water. ACS Environmental Au.",
      "log_kow_liter_liter": "7.0025",
      "source_kow": "",
      "log_dlipw_ph74_liter_liter": "6.56140115468871",
      "source_dlipw": "LSER",
      "freely_dissolved_fraction": "0.000128342763799257",
      "density_kg_liter": "",
      "source_density": "COMPTOX",
      "baseline_drerio": "0.0529923106711482",
      "baseline_dmagna": "0.146162875278843",
      "baseline_celegans": "0.331396240569914",
      "baseline_xlaevis": "0.767605851009193",
      "baseline_dmelanogaster": "1.1787582571209",
      "baseline_cells": "5.56161351645583e-05",
      "baseline_cells_generic_micromole_liter_free_ec10": "7.13792849885249e-09",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "Tetrabromobisphenol A is an antagonist of progesterone receptor (PR).",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 19,
                  "AOP_name": "Androgen receptor antagonism leading to adverse effects in the male foetus (mammals) "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 57,
                  "AOP_name": "AhR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            },
            {
                  "AOP_id": 318,
                  "AOP_name": "Glucocorticoid Receptor activation leading to hepatic steatosis "
            }
      ],
      "targets": [
            "Androgen receptor",
            "Arachidonate 12-lipoxygenase, 12S-type",
            "Arachidonate 15-lipoxygenase",
            "Cytochrome P450 2C19",
            "Cytochrome P450 2C9",
            "Estrogen receptor alpha",
            "Glucocorticoid receptor",
            "Nuclear factor erythroid 2-related factor 2",
            "Nuclear receptor subfamily 1 group I member 2",
            "Peroxisome proliferator-activated receptor alpha",
            "Peroxisome proliferator-activated receptor gamma",
            "Progesterone receptor",
            "Thyroid hormone receptor alpha",
            "Transthyretin"
      ]
}